E3 PreliminaryPreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Qualitative study of the acceptability and feasibility of acceptance and commitment therapy for adolescents with chronic fatigue syndrome.
Clery, Philippa, Starbuck, Jennifer, Laffan, Amanda et al. · BMJ paediatrics open · 2021 · DOI
Quick Summary
This study asked teenagers with ME/CFS who weren't getting better, along with their parents and doctors, what they thought about a therapy called Acceptance and Commitment Therapy (ACT). Everyone interviewed thought ACT sounded like a good option because it helps people focus on what matters to them while accepting difficult thoughts and feelings, rather than trying to fight them. Most teenagers were willing to try ACT, though they worried about being randomly assigned to different treatment groups in a future study.
Why It Matters
Many adolescents with ME/CFS remain symptomatic despite standard treatment, and finding acceptable alternative therapies is critical. This study provides evidence that ACT is viewed positively by patients, families, and clinicians, supporting the development of a larger randomised trial to test whether ACT actually improves outcomes in treatment-resistant paediatric ME/CFS.
Observed Findings
- All 30 participants (adolescents, parents, and healthcare professionals) rated ACT as acceptable for teens with treatment-resistant CFS/ME.
- Some adolescents preferred ACT over cognitive behavioural therapy because it encourages accepting thoughts rather than challenging them.
- Participants identified key perceived benefits: values-focused motivation, compassion, addressing both psychological and physical needs, and normalising difficulties.
- Healthcare professionals raised concern that patients might confuse 'acceptance' with 'giving up' without proper explanation.
- Most adolescents would consent to an RCT, but reluctance toward randomisation was identified as a significant recruitment barrier.
Inferred Conclusions
- ACT is an acceptable and feasible treatment option for adolescents with ME/CFS not responding to standard care after 12 months.
- The values-based and acceptance-oriented framework of ACT aligns with what adolescents and parents believe is helpful for chronic illness.
- An RCT of ACT is warranted, but study design must address barriers such as randomisation acceptance and individualised timing of intervention.
- Clear patient education about what 'acceptance' means is essential to prevent misunderstanding acceptance as resignation.
Remaining Questions
What This Study Does Not Prove
This qualitative study does not prove that ACT is effective at treating ME/CFS—it only shows that people find it acceptable. The study did not measure whether ACT actually improves symptoms, fatigue, or functioning. Acceptability does not equal efficacy, and further randomised controlled trials are needed to test whether ACT produces clinical benefits.
Tags
Symptom:Fatigue
Phenotype:Pediatric
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1136/bmjpo-2021-001139
- PMID
- 34660913
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →